iSpecimen Inc. Debt Securities, Available-for-sale, Unrealized Loss
iSpecimen Inc. (ISPC) reported Debt Securities, Available-for-sale, Unrealized Loss of $37.21 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2025-04-14
- iSpecimen Inc. debt securities, available-for-sale, unrealized loss for the quarter ending 2024-03-31 was $37.21K.
- iSpecimen Inc. debt securities, available-for-sale, unrealized loss for the quarter ending 2023-12-31 was $3.26K.
- iSpecimen Inc. debt securities, available-for-sale, unrealized loss for the quarter ending 2023-09-30 was $47.00.
- iSpecimen Inc. debt securities, available-for-sale, unrealized loss for the quarter ending 2023-06-30 was $18.16K.
- iSpecimen Inc. debt securities, available-for-sale, unrealized loss for fiscal 2023 was $35.30K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 6 month | Debt Securities, Available-for-sale, Unrealized Loss 9 month | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|---|---|---|
| 2024-03-31 | $37.21K 10-Q · filed 2024-05-07 | $40.47K derived: sum of 2 quarters · filed 2025-04-14 | $40.51K derived: sum of 3 quarters · filed 2025-04-14 | $58.67K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-12-31 | $3.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $3.30K derived: sum of 2 quarters · filed 2025-04-14 | $21.46K derived: sum of 3 quarters · filed 2025-04-14 | $35.30K 10-K · filed 2025-04-14 |
| 2023-09-30 | $47.00 10-Q · filed 2023-11-02 | $18.20K derived: sum of 2 quarters · filed 2023-11-02 | $32.04K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $18.16K 10-Q · filed 2023-11-02 | $25.54K 10-Q · filed 2023-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |